S84 IFB Toxicology Kits.pdf

STATE OF ARKANSAS

DEPARTMENT OF TRANSFORMATION AND SHARED SERVICES

OFFICE OF STATE PROCUREMENT

501 Woodlane St., Ste. 220 Little Rock, Arkansas 72201-1023

INVITATION FOR BID

SOLICITATION DOCUMENT

SOLICITATION INFORMATION

Solicitation Number: S000000084 Solicitation

Issued: January 25, 2022

Description: Toxicology Kits

Department: AR State Crime Laboratory

SUBMISSION DEADLINE AND DELIVERY OF RESPONSE DOCUMENTS

Bid Opening Date: January 31, 2022 Bid Opening Time: 2:00 PM, Central Time

Bid responses for this Invitation for Bid must be submitted through ARBuy, the State’s eProcurement system.

It can be accessed at https://arbuy.arkansas.gov. Bids received after the submission deadline may be rejected as untimely. See section 1.2 for information regarding Live Bid Openings.

TSS OFFICE OF STATE PROCUREMENT CONTACT INFORMATION

TSS OSP Buyer: Jennifer Trancoso Buyer’s Direct Phone Number: 501-371-6070

Email Address: Jennifer.trancoso@arkansas.gov TSS OSP’s Main Number: 501-324-9316

TSS OSP

Website: https://www.transform.ar.gov/procurement/ https://arbuy.arkansas.gov/ mailto:Jennifer.trancoso@arkansas.gov

SECTION 1 – REQUIREMENTS

• Do not provide responses to items in this section unless specifically and expressly required.

1.1 INTRODUCTION

This Invitation for Bid (IFB) is issued by the TSS Office of State Procurement (TSS OSP) for the AR State Crime Laboratory (ASCL) to obtain pricing and a contract for toxicology kits. Direct all questions, comments, or concerns you may have regarding this solicitation to the TSS Office of State Procurement, not the ASCL.

1.2 LIVE BID OPENING

Use the information below to view the bid opening online.

Zoom Meeting Link:

https://arkansas-gov.zoom.us/j/83803530177?pwd=QVNTLzdhSm1lZDdJdnpENEsyb2duZz09 Meeting ID: 838 0353 0177 Meeting Password: 443285 Dial-In Information: 877 853 5257 US Toll-free 888 475 4499 US Toll-free

1.3 CLARIFICATION OF SOLICITATION

A. Submit any questions requesting clarification of information contained in this Solicitation via the solicitation posting in ARBuy by midnight, Central Time on or before January 27th, 2022.

1. For each question submitted, Prospective Contractor should reference the specific solicitation item number to which the question refers.

2. Prospective Contractors’ written questions will be consolidated and answered by the State as deemed appropriate. The State’s consolidated written response is anticipated to be posted to the solicitation posting in ARBuy by the close of business on January 28thth, 2022. If Prospective Contractor questions are unclear or non-substantive in nature, the State may request clarification of a question(s) or decline to answer.

B. The Prospective Contractor should notify the TSS OSP buyer of any term, condition, etc., that precludes the Prospective Contractor from submitting a compliant, Responsive Bid. Prospective Contractors should note that it is the responsibility of the Prospective Contractor to seek resolution of all such issues, including those relating to the terms and conditions of the contract, prior to the submission of a bid.

C. Prospective Contractors may contact the TSS OSP buyer with non-substantive questions at any time prior to the bid opening.

D. An oral statement by TSS OSP will not be part of any contract resulting from this solicitation and may not reasonably be relied on by any Prospective Contractor as an aid to interpretation unless it is reduced to writing and expressly adopted by TSS OSP.

1.4 DEFINITION OF TERMS

A. Unless otherwise defined herein, all terms defined in Arkansas Procurement Law have the same meaning herein.

B. “Prospective Contractor” means a responsible bidder who submits a Responsive Bid in response to this solicitation.

C. The terms “Invitation For Bid”, “IFB” and “Solicitation” are used synonymously in this document.

https://arkansas-gov.zoom.us/j/83803530177?pwd=QVNTLzdhSm1lZDdJdnpENEsyb2duZz09

D. “Responsive Bid” means a bid submitted in response to this solicitation that conforms in all material respects to this IFB.

E. “Shall” and “Must” mean the imperative and are used to identify requirements.

F. “Requirement” means something required.

G. “Specification” means any technical or purchase description or other description of the physical or functional characteristics, or of the nature, of a commodity or service. “Specification” may include a description of any requirement for inspecting, testing, or preparing a commodity or service for delivery.

H. “State” means the State of Arkansas. When the term “State” is used herein to reference any obligation of the State under a contract that results from this solicitation, that obligation is limited to the Department using such a contract.

1.5 WELL PLATE (96 & 48) SPECIFICATIONS

A. Each item shall be provided as a kit. Components of the kit may vary based on the testing it is employed in. Each kit may include 96 or 48-well plate with calibrators or controls, SLE filtration plates, collection plates, beta-glucuronidase or other equivalent enzyme plates. Also, including any additional materials deemed necessary to perform the toxicology testing.

B. Item #1: 96-well plate with calibrators and controls for quantitative analysis.

1. The 96-well plate must include the following drugs:

6-Monoacetylmorphine Clonazepam Methamphetamine 7-Aminoclonazepam Cocaine Morphine Acetaminophen Codeine Nordiazepam Alprazolam Cyclobenzaprine Oxycodone Amitriptyline Diazepam Oxymorphone Amphetamine Dihydrocodeine Quetiapine Benzoylecgonine Diphenhydramine Sertraline Buprenorphine Fentanyl Tramadol Bupropion Hydrocodone Trazodone Caffeine Hydromorphone Zolpidem Carisoprodol Lorazepam Citalopram Methadone

2. ASCL reserves the right to restructure the well plate and/or internal standards drugs for Item #1 as needed.

3. Contractor shall make changes to well plate drugs and/or internal standards, based on communications from ASCL, within a fifteen (15) working day notification from ASCL.

4. The calibrators and controls must have a range of 10 – 1000 ng/mL

5. Fentanyl and 6-Monoacetylmorphine must have a range of 1 – 100 ng/mL

6. Carisoprodol must have a range of 100 – 10,000 ng/mL

7. Internal standards for Item #1 must include the following drugs:

C. Item #2: 48-well plate with calibrators and controls for blood.

1. The 48-well plate must have calibrators and controls for the following drugs:

Δ9-Tetrahydrocannabinol (THC) 11-Nor-9-carboxy-THC (THC-COOH) 11-Hydroxy-Δ9-tetrahydrocannabinol (THC-OH)

2. ASCL reserves the right to restructure the well plate and/or internal standards drugs for Item #2

3. Contractor shall make changes to well plate drugs and/or internal standards, based on communications from ASCL, within a fifteen (15) working day notification from ASCL.

4. The calibrators and controls must have a working range between 1 ng/mL – 500 ng/mL

5. Internal standards for Item #2 must include the following drugs:

THC-D3

THC-COOH-D9

THC-OH-D3

D. Item #3: 96-well plate for screening common drugs of abuse for urine.

1. The 96-well plate must have calibrators and controls for the following drugs:

Cannabidiol (CBD) [Urine plate only] Δ9-Tetrahydrocannabinol (THC) 11-Nor-9-carboxy-THC (THC-COOH) 11-Hydroxy-Δ9-tetrahydrocannabinol (THC-OH)

2. ASCL reserves the right to restructure the well plate and/or internal standards drugs for Item #3 communications from ASCL, within a fifteen (15) working day notification from ASCL.

6-Monoacetylmorphine-D6 Citalopram-D6 Morphine-D6 7-Aminoclonazepam-D4 Clonazepam-D4 Nordiazepam-D5 7-Aminoflunitrazepam-D7 Cocaine-D3 Oxycodone-D6 Acetaminophen-D4 Codeine-D6 Oxymorphone-D3 Alprazolam-D5 Cyclobenzaprine-D3 Quetiapine-D8 Amitriptyline-D3 Diazepam-D5 Sertraline-D3 Amphetamine-D11 Dihydrocodeine-D6 Tramadol-13C-D3 Benzoylecgonine-D8 Diphenhydramine-D3 Trazodone-D6 Buprenorphine-D4 Fentanyl-D5 Zolpidem-D6 Bupropion-D9 Hydrocodone-D6 Caffeine-13C3 Hydromorphone-D6 Carisoprodol-D7 Methadone-D9

4. The calibrators and controls must have a working range between 1 ng/mL – 500 ng/mL

5. Internal standards for Item #3 must include the following drugs:

Cannabidiol-D3 [Urine plate only]

THC-D3

THC-COOH-D9

THC-OH-D3

E. Item #4: 96-well plate for screening common drugs of abuse for blood.

1. The 96-well plates must be designed to include analytes listed in the table below:

6-MAM Estazolam Naproxen 7-aminoclonazepam Etizolam Nitrazepam 7-aminoflunitrazepam Fentanyl Nordiazepam Acetaminophen Flunitrazepam Norfluoxetine Acetyl Fentanyl Fluoxetine Nortriptyline Alprazolam Flurazepam Ondansetron Amitriptyline Gabapentin Oxazepam Amphetamine Haloperidol Oxycodone Atropine Hydrocodone Oxymorphone Benzoylecgonine Hydromorphone Phenazepam Buprenorphine Hydroxyzine Phencyclidine Bupropion Ibuprofen Phentermine Butabarbital Imipramine Phenytoin Carbamazepine Levamisole Promethazine Carisoprodol Loratidine Propoxyphene Cetirizine Lorazepam Quetiapine Chlordiazepoxide MDA Sertraline Citalopram MDMA Tapentadol Clonazepam Meperidine Temazepam Cocaine Meprobamate THC Codeine Methadone THC-COOH Cyclobenzaprine Methamphetamine THC-OH Desipramine Methylphenidate Tramadol Dextromethorphan Metoprolol Trazodone Diazepam Midazolam Valproic Acid Dihydrocodeine Mirtazapine Venlafaxine Diphenhydramine Mitragynine Zolpidem Doxepin Morphine Doxylamine Naloxone

2. ASCL reserves the right to restructure the well plate and/or internal standards drugs for common drugs of abuse as needed.

communications from ASCL, within a fifteen (15) business day notification from ASCL.

4. Contractor shall incorporate deuterated internal standards corresponding to individual analytes specified in the table above with the exceptions noted below:

a. Should no suitable corresponding internal standard be available, appropriate surrogate internal standards must be discussed with ASCL prior to plate manufacture.

5. Contractor shall notify ASCL fifteen (15) working days prior to order shipment, of any of the corresponding internal standards, not included in the individual analytes as specified in the table above.

F. Item #5: 96-well plate for screening common drugs of abuse for urine.

1. The 96-well plates must be designed to include analytes listed in the table below:

6-MAM Estazolam Naproxen 7-aminoclonazepam Etizolam Nitrazepam 7-aminoflunitrazepam Fentanyl Nordiazepam Acetaminophen Flunitrazepam Norfluoxetine Acetyl Fentanyl Fluoxetine Nortriptyline Alprazolam Flurazepam Ondansetron Amitriptyline Gabapentin Oxazepam Amphetamine Haloperidol Oxycodone Atropine Hydrocodone Oxymorphone Benzoylecgonine Hydromorphone Phenazepam Buprenorphine Hydroxyzine Phencyclidine Bupropion Ibuprofen Phentermine Butabarbital Imipramine Phenytoin Carbamazepine Levamisole Promethazine Carisoprodol Loratidine Propoxyphene Cetirizine Lorazepam Quetiapine Chlordiazepoxide MDA Sertraline Citalopram MDMA Tapentadol Clonazepam Meperidine Temazepam Cocaine Meprobamate THC Codeine Methadone THC-COOH Cyclobenzaprine Methamphetamine THC-OH Desipramine Methylphenidate Tramadol Dextromethorphan Metoprolol Trazodone Diazepam Midazolam Valproic Acid Dihydrocodeine Mirtazapine Venlafaxine Diphenhydramine Mitragynine Zolpidem Doxepin Morphine Doxylamine Naloxone

2. ASCL reserves the right to restructure the well plate and/or internal standards drugs for common drugs of abuse as needed.

communications from ASCL, within a fifteen (15) business day notification from ASCL.

4. Contractor shall incorporate deuterated internal standards corresponding to individual analytes specified in the table above with the exceptions noted below:

a. Should no suitable corresponding internal standard be available, appropriate surrogate internal standards must be discussed with ASCL prior to plate manufacture.

5. Contractor shall notify ASCL fifteen (15) working days prior to order shipment, of any of the corresponding internal standards, not included in the individual analytes as specified in the table above.

G. Sample preparation plate, Isolute SLE+plate, ß-glucuronidase plate, for respective urine assays and collection plate must be included.

1. Analysis plates must include but not be limited to the following:

a. Be pre-manufactured and sealed.

b. Be packaged to minimize damage during shipping and storage.

c. Have a minimum shelf life of six (6) months without any degradation under frozen conditions.

2. Sample preparation plates must include but not limited to the following:

a. Multi-analyte mixtures of NIST traceable certified reference standards relevant to the methods of analyses listed in this IFB.

b. Sample preparation plates must be manufactured with:

i. Calibrators

ii. Wherever applicable, quality control materials should be provided from a secondary source, prepared and analyzed with the samples.

iii. Internal standards at precise concentrations allowed for simple and consistent sample preparation.

3. Certificates of analysis of analytes must be included with delivery of the sample preparation plates.

H. Validation plates and individual stock solutions of calibrators associated with validation plates.

a. Validation plates will be ordered whenever the need arises for the development of new analytical methods. The analytes included and their associated ranges will be discussed between the manufacturer and the ASCL before procurement.

1.6 PROSPECTIVE CONTRACTOR QUALIFICATIONS

A. A copy of the ISO/IEC 17025 or equivalent accreditation certificate should be included with the response packet, or must be provided, when requested by the Office of State Procurement or AR State Crime Lab within three (3) calendar days from the request.

B. Prospective Contractor shall have a minimum of one (1) year experience providing SLE plates for toxicology testing of biological specimens to laboratories located in the continental United States.

C. Prospective Contractor shall be a manufacturer, or an approved distributor, of the brand referenced on the Official Bid Price Sheet.

D. The State of Arkansas reserves the right to request verification of manufacturer, or an approved distributor, prior to Anticipation to Award.

1.7 NEW TOXICOLOGY TESTING KITS

A. The State intends to obtain for the duration of this contract or any contract extensions thereof products that reflect the industry’s latest Drug Testing Qualitative Toxicology Testing Kit technology.

The State recognizes that there will be Drug Testing Qualitative Toxicology Kit testing technological modifications and improvements that will become available during the life of this contract that will be unavailable on the date of the contract award.

B. New items, or items not previously tested, must be available to the Arkansas State Crime Laboratory at discounted contract pricing. (e.g. Well plates in a different configuration than identified in this IFB)

C. New well plate items must receive the same pricing parameters as other items listed in this IFB.

D. No penalties will be incurred by the Arkansas State Crime Lab for any returned items.

1.8 BACKGROUND

On July 10, 2014, the ASCL received accreditation through the ASCLD/LAB-International program. This program is based on the ISO/IEC 17025 standards for the competence of testing laboratories, with supplemental requirements based on the needs of the forensic science discipline.

1.9 REFERENCES

The State of Arkansas reserves the right to request references and/or documented proof of experience, prior to Anticipation to Award.

1.10 PRICE ESCALATION

A. Price increases will be considered at the time of contract renewal.

B. The Contractor must provide to OSP a written request for the price increase. The request must include supporting documentation demonstrating that the increase in contract price is based on an increase in market price. OSP has the right to require additional information pertaining to the requested increase.

C. Increases will not be considered to increase profit or margins.

D. OSP has the right to approve or deny the request.

1.11 DELIVERY: FOB DESTINATION

Arkansas State Crime Lab Attention: Kristen Mauldin #3 Natural Resource Drive Little Rock, AR 72205

A. The Department requests delivery within 30 working days after ordering. If this delivery date cannot be met, the Prospective Contractor must state the alternate number of days required to begin the service and/or place the commodity in the ordering Department’s designated location. (See Questions section of the Solicitation posting in ARBuy.) Failure to state the alternate delivery time obligates the Contractor to complete delivery by the Department’s requested date. Extended delivery dates may be considered when in the best interest of the State.

B. All deliveries must be made during normal State work hours (8:00 am to 4:00 pm CT) and within the agreed upon number of days unless otherwise arranged and coordinated with the Department. The Contractor shall give the Department immediate notice of any anticipated delays or plant shutdowns that will affect the delivery requirement.

C. Loss or damage that occurs during shipping, prior to the order being received by the Department, is the

Contractor’s responsibility. All orders should be properly packaged to prevent damage during shipping.

D. The State assumes no liability for commodities produced, processed, or shipped in excess of the amount specified on the Department’s purchase order.

1.12 ACCEPTANCE STANDARDS

A. Inspection and acceptance/rejection of product(s) will be made within thirty (30) days of receipt.

B. The State has the option to return any product(s) within the thirty (30) day timeframe for any reason.

C. Bid must include a “total satisfaction” return policy for all products and must not impose any liability on the State for such returns.

SECTION 2 – GENERAL INSTRUCTIONS AND INFORMATION

• Do not provide responses to items in this section unless specifically and expressly required.

2.2 TYPE OF CONTRACT

A. As a result of this IFB, TSS OSP intends to award a contract to a single Contractor.

B. The anticipated starting date for any resulting contract is upon contract award, except that the actual contract start date may be adjusted unilaterally by the State for up to three (3) calendar months. By submitting a signed bid in response to the IFB, the Prospective Contractor represents and warrants that it will honor its bid as being held open as irrevocable for this period.

C. The initial term of a resulting contract will be for one (1) year. Upon mutual agreement by the

Contractor and Department, the contract may be renewed by TSS OSP for up to six (6) additional one-year terms or portions thereof, not to exceed a total aggregate contract term of seven (7) consecutive years.

2.3 CONTRACTOR SELECTION

A. Award will be made to the lowest-bidding, responsible Prospective Contractor on all or none basis.

B. Prospective Contractor shall have an accreditation of ISO/IEC 17025 or equivalent to be determined by ASCL.

2.4 RESPONSE DOCUMENTS

A. All bid responses must be submitted through ARBuy, the State’s eProcurement system. The system can be accessed at https://arbuy.arkansas.gov.

B. Bid Response Packet

1. The following are bid submission requirements and must be submitted as part of a Prospective

Contractor’s bid response.

a. Signed Bid Signature Page. Signature may be ink or digital. (See Bid Response Packet.)

https://arbuy.arkansas.gov/

b. Completed Bid Response Packet, which must be in the English language.

c. Completed Pricing Response in ARBuy. Pricing must be proposed in U.S. dollars and cents.

d. Proposed Subcontractors Form. The utilization of any proposed subcontractor is subject to approval by the Department.

e. Exceptions Form.

2. The following items, which must be submitted prior to a contract award to the Prospective Contractor, may also be included with the Prospective Contractor’s bid response:

a. EO 98-04 Contract & Grant Disclosure Form.

b. Copy of Prospective Contractor’s Equal Opportunity Policy.

3. DO NOT include any other documents or ancillary information, such as a cover letter or promotional/marketing information.

2.5 ACCEPTANCE OF REQUIREMENTS

A. Unless a Prospective Contractor expressly and conspicuously identifies any exception or exceptions to any of the Requirements in the Requirements Section(s) of this IFB by listing them on the Exceptions Form (See Bid Response Packet), Prospective Contractor understands and agrees its submission of a bid to represent that its bid meets all such Requirements.

B. A Prospective Contractor’s bid may be rejected if the Prospective Contractor takes exception to any Requirements in the Requirements Section(s) of this IFB.

2.6 ADDITIONAL TERMS AND CONDITIONS

A. This IFB incorporates all of the Solicitation Terms and Conditions located on the TSS OSP website here (Agencies – Forms and Reporting – Solicitation Templates):

https://www.transform.ar.gov/procurement/agencies/forms-and-reporting/.

B. Any special terms and conditions included in this solicitation shall override the Solicitation Terms and Conditions.

C. Unless a Prospective Contractor expressly and conspicuously identifies any exception or exceptions to any of the terms in the Standard Commodities Contract by listing them on the Exceptions Form (See Bid Response Packet), Prospective Contractor agrees and shall adhere to all terms if selected as the successful Contractor. Items identified as non-negotiable may only be modified if the legal requirement is satisfied and approved by the State. The Standard Commodities Contract can be viewed on the TSS OSP website here (Agencies – Forms and Reporting – Solicitation Templates):

https://www.transform.ar.gov/procurement/agencies/forms-and-reporting/.

D. A Prospective Contractor’s bid may be rejected if a Prospective Contractor takes exception to any terms or conditions in the documents listed in 2.6.A and 2.6.C.

https://www.transform.ar.gov/procurement/agencies/forms-and-reporting/ https://www.transform.ar.gov/procurement/agencies/forms-and-reporting/

SECTION 2 – GENERAL INSTRUCTIONS AND INFORMATION